Haleon (HLN) Enterprise Value (2021 - 2026)
Haleon's (HLN) quarterly Enterprise Value came in at -$882.8 million in Q2 2026, up 50.94% on a QoQ basis from -$1.8 billion in Q4 2025.
Haleon (HLN) Enterprise Value (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Enterprise Value data on file, last reported at -$882.8 million in Q2 2026.
- Quarterly Enterprise Value changed N/A year-over-year to -$882.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$882.8 million (changed N/A YoY) and the FY2025 annual result came in at -$1.8 billion, up 39.81% from the prior year.
- Enterprise Value climbed to -$882.8 million in Q2 2026, from -$1.8 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$235.3 million in Q2 2023 to a low of -$3.0 billion in Q4 2024.
- A 5-year average of -$1.2 billion and a median of -$1.0 billion in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value surged 86.42% — and 2024, when it slumped 154.37%.
- Tracing HLN's Enterprise Value over 5 years: stood at -$713.1 million in 2022, then slumped by 64.29% to -$1.2 billion in 2023, then tumbled by 154.37% to -$3.0 billion in 2024, then surged by 39.62% to -$1.8 billion in 2025, then surged by 50.94% to -$882.8 million in 2026.
- The last three Enterprise Value figures came in at -$882.8 million (Q2 2026), -$1.8 billion (Q4 2025), and -$3.0 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -882.82 Mn |
| Dec 31, 2025 | -1.80 Bn |
| Dec 31, 2024 | -2.98 Bn |
| Jun 30, 2024 | -406.44 Mn |
| Dec 31, 2023 | -1.17 Bn |
| Jun 30, 2023 | -235.26 Mn |
| Dec 31, 2022 | -713.14 Mn |
| Jun 30, 2022 | -1.73 Bn |
| Dec 31, 2021 | -396.32 Mn |